Tech Company Financing Transactions
TandemAI Funding Round
Chengwei Ventures, OrbiMed and private investors participated in a $25 million Seed capital raise for TandemAI. The financing was recorded on 12/29/2021.
Transaction Overview
Company Name
Announced On
12/29/2021
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Seed
Investors
Chengwei Ventures (Lead Investor)
OrbiMed (Lead Investor) (David Wang)
Proceeds Purpose
The funds will accelerate our expansion and enable us to attract the best talent for our platform and discovery operations.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Building 10 No. 860 Xinyang Rd. Lingang New Area Pilot Free
Shanghai, 201208
China
Shanghai, 201208
China
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
TandemAI is an advanced technology company dedicated to reinventing drug discovery infrastructure. The company integrates proprietary AI-driven, high-performance computation with its efficient, large-scale in-house wet lab operations to deliver a turnkey drug discovery solution.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeff He
Browse more venture capital transactions:
Prev: 12/28/2021: Glassbeam venture capital transaction
Next: 12/29/2021: GlobalBees venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC investment data records on this site are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs